Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DTILthis companyPrecision BioSciences, Inc.	$10.38	-1.17×	0.58×	1.56×	0.68×	-257.3%	100.0%	-152.2%	-133.4%	-49.6%	-35.5%	-123.6%	0.31×	1.93×	-36.67×	13.32×	0.0%	3	-4.84	1	C-
ABOSAcumen Pharmaceuticals, Inc.	$0.24	-1.06×	1.81×	0×	-0.9×	56.7%	0.0%	0.0%	0.0%	-172.3%	-121.7%	-90.5%	0.44×	0.19×	-29.32×	4.07×	0.0%	2	-11.67	2	C
ALECAlector, Inc.	$2.45	-1.12×	5.24×	7.63×	-0.99×	-108.0%	54.1%	-692.8%	-679.2%	-466.3%	-62.5%	-114.6%	1.18×	0.22×	0×	3.83×	0.0%	2	-7.33	2	C
GOSSGossamer Bio, Inc.	$10.47	-4.16×	-5.77×	14.62×	-5.51×	1153.6%	97.9%	-336.8%	-351.5%	138.8%	-148.7%	-24.2%	-1.65×	-1.04×	-14.86×	2.64×	0.0%	3	-35.69	2	C+
HRTXHeron Therapeutics, Inc.	$0.39	-10.83×	15.12×	1.4×	-18.38×	-4735.4%	73.3%	-1.6%	-13.0%	-140.9%	-1.6%	-12.9%	9.81×	-6.26×	0×	2.48×	0.0%	2	-9.84	2	C
QTTBQ32 Bio Inc.	$9.36	1.37×	0.97×	0.76×	0.25×	5.9%	100.0%	31.5%	55.5%	71.0%	29.5%	-82.1%	0.37×	-1.05×	15.37×	4.85×	0.0%	5	15.46	5	A+
Peer median	—	-1.12×	1.81×	1.4×	-0.99×	5.9%	73.3%	-1.6%	-13.0%	-140.9%	-62.5%	-82.1%	0.44×	-1.04×	0×	3.83×	0.0%	2	-9.84	2	—